Extensions

To determine the patent term adjustments (PTA), patent term extensions (PTE), continuation applications, divisional applications, related family members, and the projected expiration date for US patent 10946284, I will analyze the provided patent text and general patent law principles. The USPTO does not calculate expiration dates for patents, but provides resources to help estimate them.

Patent Term Adjustment (PTA) and Patent Term Extension (PTE)

• Patent Term Adjustment (PTA): PTA is granted to compensate patent applicants for delays incurred during the prosecution of a patent application before the USPTO. It extends the patent term beyond the statutory 20 years from the earliest filing date. The patent text for US10946284 does not explicitly state the amount of PTA granted. To determine this, one would typically need to consult the patent's file wrapper on the USPTO's Patent Center.
• Patent Term Extension (PTE): PTE is awarded to compensate for delays in obtaining regulatory approval on a patented product or methods of manufacturing or using the product. Given the nature of US10946284, which relates to virtual gameplay, it is highly unlikely to be eligible for PTE, as PTE is primarily relevant for patents covering products requiring regulatory approval (e.g., pharmaceuticals). The patent text does not indicate any PTE has been granted.

Continuation and Divisional Applications

US patent 10946284 is a result of a continuation application. The patent text explicitly states: "This application is a continuation of U.S. application Ser. No. 14/084,113, filed Nov. 19, 2013, which claims priority to U.S. Provisional Application No. 61/796,715, filed Nov. 19, 2012, which is incorporated herein by reference in its entirety."

The following applications are listed as "Priority Applications" or "Family Applications" and indicate a chain of continuation applications claiming priority from the initial filing:

• US15/215,406: This is the application number for US10946284 itself, filed on 2016-07-20, claiming priority to 2012-11-19.
• US17/172,623 (US11484797B2): A continuation, filed 2021-02-10, claiming priority to 2012-11-19.
• US17/952,026 (US11666827B2): A continuation, filed 2022-09-23, claiming priority to 2012-11-19.
• US18/205,206 (US12070691B2): A continuation, filed 2023-06-02, claiming priority to 2012-11-19.
• US18/813,579 (US20240416243A1): A pending application, filed 2024-08-23, claiming priority to 2012-11-19.
• US19/175,119 (US20250235790A1): A pending application, filed 2025-04-10, claiming priority to 2012-11-19.
• US19/176,364 (US20250235791A1): A pending application, filed 2025-04-11, claiming priority to 2012-11-19.
• US19/356,374 (US20260034457A1): A pending application, filed 2025-10-13, claiming priority to 2012-11-19.
• US19/356,347 (US20260034456A1): A pending application, filed 2025-10-13, claiming priority to 2012-11-19.

The patent text does not explicitly mention any divisional applications directly originating from US10946284 itself or its immediate parent, US14/084,113, based on a restriction requirement. However, continuation applications, as listed above, are a common way to pursue claims to different aspects of an invention disclosed in an earlier application.

Related Family Members

The "Priority Applications" and "Family Applications" sections within the patent document list several related family members, all stemming from the same priority date:

• US201261796715P: U.S. Provisional Application, filed 2012-11-19 (the earliest priority date).
• US14/084,113 (US20140141889A1): The parent non-provisional application, filed 2013-11-19, from which US10946284 is a continuation.
• The continuation applications listed above (US17/172,623, US17/952,026, US18/205,206, US18/813,579, US19/175,119, US19/176,364, US19/356,374, US19/356,347).
• US20160325183A1: An earlier publication of the application leading to US10946284.

Projected Expiration Date

Under U.S. law, the term of a patent (other than a design patent) is generally 20 years from the date on which the earliest non-provisional application in its priority chain was filed. For US10946284, the earliest priority date is November 19, 2012, from U.S. Provisional Application No. 61/796,715.

Therefore, the statutory expiration date (before any PTA) would be 20 years from November 19, 2012.

• Priority Date: 2012-11-19
• Statutory 20-year term ends: 2032-11-19

The patent text for US10946284 explicitly states an "Anticipated expiration" date of 2033-11-19. This indicates that a Patent Term Adjustment (PTA) of approximately one year has been granted to US10946284, extending its term by one year beyond the standard 20 years from its earliest priority date. [cite: The patent itself, section "Legal status"]

• Anticipated expiration date (including PTA): 2033-11-19 [cite: The patent itself, section "Legal status"]

This expiration date is critical, especially in patent families with continuation or divisional applications, for assessing potential obviousness-type double patenting (ODP) issues. If a patent has a terminal disclaimer, the expiration date specified in the disclaimer governs, and PTA does not extend the term beyond that disclaimed date. The provided text does not explicitly mention a terminal disclaimer for US10946284, but its presence would affect the final expiration.